Displaying results 1 - 1 of 1
Clear search
Abzena appoints Thomas Castellano as Chief Financial Officer
Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Thomas Castellano, as Chief Financial Officer.